Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 2 Leukemia 2 Triple Negative Breast Neoplasms 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cancer Recurrent 1 Neoplasm Metastasis 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Influenza, Human 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 2 Paclitaxel 2 Carboplatin 2 poly(I).poly(c12,U) 1 liposomal doxorubicin 1 Lenalidomide 1 Interferon alpha-2 1 Gemcitabine 1 Cisplatin 1 Bevacizumab 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Ovarian Cancer Recurrent × Interferon alpha-2 × Clear all

NCT04072263 2021-04-01

OVACURE

Leiden University Medical Center

Phase 1/2 Unknown

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡